摘要
目的 :研究用依达拉奉治疗急性脑梗死的临床效果。方法 :选择常州市肿瘤医院于2014年9月至2016年2月期间收治的80例急性脑梗死患者作为本文的研究对象。随机将这80例患者分为对照组(n=40)和治疗组(n=40)。采用常规疗法对两组患者进行治疗。在此基础上,对治疗组患者加用依达拉奉进行治疗,然后比较两组患者治疗前后的ESS评分、ADL评分及其治疗的有效率。结果 :接受治疗前及治疗后7 d,两组患者的ESS评分及ADL评分相比差异无统计学意义(P>0.05)。接受治疗后的第14 d、第21 d和第90 d,治疗组患者的ESS评分和ADL评分均高于对照组患者,差异有统计学意义(P<0.05)。治疗组患者治疗的有效率高于对照组患者,差异有统计学意义(P<0.05)。结论 :临床上在使用常规疗法对急性脑梗死患者进行治疗的同时,加用依达拉奉对其进行治疗的效果十分理想,能有效地改善其神经功能缺损的症状,提高其日常生活能力。
Objective： To study effect of edaravone for acute cerebral infarction. Methods： Select 80 cases of acute cerebral infarction patients treated in our hospital from September 2014 to February 2016, randomly divided the cases into experimental group （ n=40 ） and control group （ n=40 ） .We treat 2 group with routine treatment,base on it,treat experimental group with edaravone. Then compare ESS score and ADL score of 2 groups before and after treatment, and compare effective rate of 2 groups. Results： The ESS score and ADL score of 2 groups have no statistical significant before treatment and in the first 7 days of treatment process （ P ~ 0.05 ） In the 14th day,21th day and 90th day, the average ESS score and the average ADL score of experimental group are higher than control group（P 〈 0.05）. Effective rate in experimental group is higher than control group （ P 〈 0.05 ） .Conclusion： Use edaravone in the treatment process of the patients with acute cerebral infarction can get a good effect. This therapy can improve symptom of neurological impairment and living ability of the patients.
